Find a Clinical Trial
Filter
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy (CAMBRIA-1)
All genders
18+
Recruiting now
Cancer Center
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast cancer
All genders
18+
Recruiting now
Cancer Center
CHASM CS-RCT
Cardiac sarcoidosis
All genders
18+
Recruiting now
CardioVascular Center
Cardiovascular Biorepository
Cardiovascular diseases
All genders
No minimum age
Recruiting now
CardioVascular Center
CATALYST Trial
Atrial fibrillation
All genders
18+
Recruiting now
CardioVascular Center
Community Walks: Clinical Trial
Cardiovascular conditions
All genders
18+
Recruiting now
Department of Medicine, Division of General Internal Medicine
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
Breast cancer
All genders
16+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Effects of BCR-ABL tyrosine kinase inhibitors on platelets and white blood cells
All genders
18+
Recruiting now
CardioVascular Center
EXPAND TAVR II
Heart failure
All genders
65+
Recruiting now
CardioVascular Center
FACT-CRT
Cardiac failure, Heart failure
All genders
18+
Recruiting now
CardioVascular Center